scispace - formally typeset
O

Osondu Ogbuoji

Researcher at Duke University

Publications -  67
Citations -  1045

Osondu Ogbuoji is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Global health. The author has an hindex of 10, co-authored 42 publications receiving 566 citations. Previous affiliations of Osondu Ogbuoji include Durham University & Harvard University.

Papers
More filters
Journal ArticleDOI

Interventions to improve adherence to antiretroviral therapy: a rapid systematic review

TL;DR: A rapid systematic review of the global evidence on interventions that can improve adherence to ART, including individual-level interventions and changes to the structure of ART delivery, to inform the evidence base for the 2013 WHO consolidated antiretroviral guidelines.
Journal ArticleDOI

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.

Sarah Wulf Hanson, +126 more
- 10 Oct 2022 - 
TL;DR: This study presents estimates of the proportion of individuals with at least 1 of the 3 self-reported Long COVID symptom clusters in 2020 and 2021, which were more common in women aged 20 years or older by sex and for both sexes of nonhospitalized individuals younger than 20 years of age.
Journal ArticleDOI

A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care

TL;DR: This systematic review aims to determine which interventions improve retention within prevention of mother‐to‐child HIV transmission (PMTCT) programmes after birth, transitioning from PMTCT to general ART programmes in the postpartum period, and retention of post partum women in general ART programs.
Journal ArticleDOI

Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.

TL;DR: Developing a safe, effective vaccine alone will not be enough to end the pandemic; the vaccine must also be delivered globally at a price affordable to all governments and allocated in a way that maximises immediate and long-term public health impact and simultaneously achieves equity.